Pfizer Seeks Approval for Oral COVID-19 Antiviral Paxlovid
Paxlovid consists of nirmatrelvir and low-dose ritonavir.
Paxlovid consists of nirmatrelvir and low-dose ritonavir.
Amid the global COVID-19 pandemic that overwhelmed hospitals, upended the economy, and sent much of the world into lockdown, researchers tracked a concerning uptick in alcohol use.
The author describes the evolution of the workweek and how shortening the expected hours for full-time work without a decrease in compensation may increase the well-being of health care providers while not decreasing current productivity.
In an international online study participants completed a questionnaire to identify experiences of depersonalization and vividness of positive or negative emotions before and during COVID-19.
The trial evaluated booster doses of the Omicron-adapted vaccine candidates.
No crisis should go unexploited for its potential to improve health care delivery.
Using a shortened Nature Relatedness Scale, the Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS), and sociodemographic information, the researchers surveyed 386 individuals aged 18 to 65 about their feelings of connection to nature and mental well-being.
The FDA evaluation included an analysis of safety, effectiveness and manufacturing data of these vaccines.
According to the CDC, as of June 7, 2022, there have been over 13.1 million cases of COVID-19 among children and adolescents 0 to 17 years of age.
The study evaluated Paxlovid in both vaccinated and unvaccinated patients with COVID-19 at standard risk for progressing to severe disease.